AI MARKET SCANNING

BioMarin Pharmaceutical Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.81%
MAX GAP RECORD +9.10%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $BMRN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 26, 2026 Earnings Release 2026-10-26 (AFTER CLOSE (16:00))
-0.34%
Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
+5.48%
May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE)
+0.68%
Feb 23, 2026 Earnings Release 2026-02-23 (AFTER CLOSE)
-4.16%
Oct 27, 2025 Earnings Release 2025-10-27 (AFTER CLOSE)
+1.39%
Aug 04, 2025 Earnings Release 2025-08-04 (AFTER CLOSE)
+5.02%
Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE)
-0.77%
Feb 19, 2025 Earnings Release 2025-02-19 (AFTER CLOSE)
+6.69%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.9%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $BMRN

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-27 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1490m +0.68%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗